ZymoGenetics, Inc. (ZGEN) Reports Third Quarter 2009 Financial Results
11/6/2009 10:13:32 AM
More...
|
King Pharmaceuticals®, Inc. Sues ZymoGenetics, Inc. (ZGEN) Alleging Trademark Violation
11/4/2009 6:24:01 AM
More...
|
Bristol-Myers Squibb Company (BMY) and ZymoGenetics, Inc. (ZGEN) Present Final Phase 1b Results for PEG-Interferon Lambda in Hepatitis C
11/2/2009 9:27:01 AM
More...
|
ZymoGenetics, Inc. (ZGEN) to Webcast Presentation at Oppenheimer Healthcare Conference
10/28/2009 9:42:03 AM
More...
|
ZymoGenetics, Inc. (ZGEN) Initiates Phase 2 Clinical Trial of PEG-Interferon lambda in Hepatitis C with Bristol-Myers Squibb Company (BMY) (JOBS)
10/27/2009 10:04:15 AM
More...
|
ZymoGenetics, Inc. (ZGEN) Starts Study, Receiving $70 Million from Bristol-Myers Squibb Company (BMY) (JOBS)
10/27/2009 7:40:35 AM
More...
|
ZymoGenetics, Inc. (ZGEN)'s Former Medical Boss Leads Rival Startup, ProFibrix, With Drug For Bleeding
10/26/2009 7:56:50 AM
More...
|
ZymoGenetics, Inc. (ZGEN) to Host Conference Call and Webcast on November 5, 2009 to Discuss Third Quarter 2009 Financial Results
10/15/2009 8:32:41 AM
More...
|
Bristol-Myers Squibb Company (BMY) and ZymoGenetics, Inc. (ZGEN) to Present Final Phase Ib Data on PEG-Interferon Lambda at AASLD 2009
10/1/2009 11:06:13 AM
More...
|
ZymoGenetics, Inc. (ZGEN) (JOBS) Says Merck Serono Discontinues MS Trials
9/28/2009 6:27:01 AM
More...
|
|